
JHU Med Scientists Create Nanobody That Can Punch Through Tough Brain Cells
New research: A mini-version of antibodies, called nanobodies, could eventually be used to treat neurocognitive disorders.
New research: A mini-version of antibodies, called nanobodies, could eventually be used to treat neurocognitive disorders.
Andrew Nelson is a thought leader in entrepreneurship, diffusion of technology innovations, and commercialization of University Research. He profoundly influenced Visible Legacy as we got started while he was completing his PhD at Stanford University. Dr Nelson is now Associate Professor of Management at the University of Oregon. Of interest to industry Tech Scouts, he authored a book in 2014 "Technology Ventures: From Idea to Enterprise" with Tom Byers and Richard Dorf.